Role of the N- and C-terminal domains in binding of apolipoprotein E isoforms to heparan sulfate and dermatan sulfate: a surface plasmon resonance study.
暂无分享,去创建一个
Y. Yamauchi | M. Nakano | H. Saito | T. Handa | M. Phillips | S. Lund-Katz | P. Dhanasekaran | Masafumi Tanaka | N. Deguchi | Chika Takagi
[1] H. Saito,et al. Contributions of the carboxyl-terminal helical segment to the self-association and lipoprotein preferences of human apolipoprotein E3 and E4 isoforms. , 2008, Biochemistry.
[2] J. Seelig,et al. Melittin interaction with sulfated cell surface sugars. , 2008, Biochemistry.
[3] Radiya M. Sojitrawala,et al. A monomeric, biologically active, full-length human apolipoprotein E. , 2007, Biochemistry.
[4] R. Mahley,et al. Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing. , 2007, The Journal of clinical investigation.
[5] J. Esko,et al. Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. , 2007, The Journal of clinical investigation.
[6] K. Weisgraber,et al. Apolipoprotein E structure: insights into function. , 2006, Trends in biochemical sciences.
[7] H. Saito,et al. Effect of carboxyl-terminal truncation on structure and lipid interaction of human apolipoprotein E4. , 2006, Biochemistry.
[8] J. Seelig,et al. Structural and thermodynamic aspects of the interaction between heparan sulfate and analogues of melittin. , 2006, Biochemistry.
[9] A. Rapp,et al. Role of chondroitin sulphate in the uptake of β‐VLDL by brain cells , 2005 .
[10] P. Axelsen,et al. Structural analysis of lipoprotein E particles. , 2005, Biochemistry.
[11] K. Williams,et al. Loss of heparan N-sulfotransferase in diabetic liver: role of angiotensin II. , 2005, Diabetes.
[12] Hiroyuki Saito,et al. Two-step Mechanism of Binding of Apolipoprotein E to Heparin , 2005, Journal of Biological Chemistry.
[13] J. Borén,et al. Mechanism of lipoprotein retention by the extracellular matrix , 2004, Current opinion in lipidology.
[14] A. Chait,et al. Increase in Serum Amyloid A Evoked by Dietary Cholesterol Is Associated With Increased Atherosclerosis in Mice , 2004, Circulation.
[15] K. Weisgraber,et al. Effects of Polymorphism on the Lipid Interaction of Human Apolipoprotein E* , 2003, Journal of Biological Chemistry.
[16] S. Wehrli,et al. Characterization of the Heparin Binding Sites in Human Apolipoprotein E* , 2003, The Journal of Biological Chemistry.
[17] M. Togo,et al. Isoform-Dependent Cholesterol Efflux From Macrophages by Apolipoprotein E Is Modulated by Cell Surface Proteoglycans , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[18] R. E. Pitas,et al. Evidence for differential effects of apoE3 and apoE4 on HDL metabolism Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200172-JLR200 , 2002, Journal of Lipid Research.
[19] A. Chait,et al. Apolipoprotein E Mediates the Retention of High-Density Lipoproteins by Mouse Carotid Arteries and Cultured Arterial Smooth Muscle Cell Extracellular Matrices , 2002, Circulation research.
[20] R. Linhardt,et al. Inhibition of apolipoprotein E-related neurotoxicity by glycosaminoglycans and their oligosaccharides. , 2002, Biochemistry.
[21] R. Linhardt,et al. Heparin-protein interactions. , 2002, Angewandte Chemie.
[22] K. Weisgraber,et al. Lipid Binding-induced Conformational Change in Human Apolipoprotein E , 2001, The Journal of Biological Chemistry.
[23] Ishan Capila,et al. New Insights into the Heparan Sulfate Proteoglycan-binding Activity of Apolipoprotein E* , 2001, The Journal of Biological Chemistry.
[24] J. Moses,et al. Glycosaminoglycan-lipoprotein interaction , 2001, Glycoconjugate Journal.
[25] O. Klezovitch,et al. Domains of apolipoprotein E involved in the binding to the protein core of biglycan of the vascular extracellular matrix: potential relationship between retention and anti-atherogenic properties of this apolipoprotein. , 2001, Trends in cardiovascular medicine.
[26] D. Hui,et al. Apolipoprotein E Receptor Binding VersusHeparan Sulfate Proteoglycan Binding in Its Regulation of Smooth Muscle Cell Migration and Proliferation* , 2001, The Journal of Biological Chemistry.
[27] Z. Huang,et al. Interaction with proteoglycans enhances the sterol efflux produced by endogenous expression of macrophage apoE. , 2001, Journal of lipid research.
[28] M C Phillips,et al. Effects of polymorphism on the microenvironment of the LDL receptor-binding region of human apoE. , 2001, Journal of lipid research.
[29] B. Rupp,et al. Interaction of the N-terminal domain of apolipoprotein E4 with heparin. , 2001, Biochemistry.
[30] Suzanne Wehrli,et al. Effects of Lipid Interaction on the Lysine Microenvironments in Apolipoprotein E* , 2000, The Journal of Biological Chemistry.
[31] O. Klezovitch,et al. Structural Determinants in the C-terminal Domain of Apolipoprotein E Mediating Binding to the Protein Core of Human Aortic Biglycan* , 2000, The Journal of Biological Chemistry.
[32] Yan Xu,et al. Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice. , 2000, The Journal of clinical investigation.
[33] R. Colman,et al. Kinetic analysis of the role of zinc in the interaction of domain 5 of high-molecular weight kininogen (HK) with heparin. , 2000, Biochemistry.
[34] M. Germann,et al. Design of Peptides with High Affinities for Heparin and Endothelial Cell Proteoglycans* , 2000, The Journal of Biological Chemistry.
[35] S. Smith‐Gill,et al. Experimental design for analysis of complex kinetics using surface plasmon resonance. , 2000, Methods.
[36] G. Siest,et al. Kinetics of apolipoprotein E isoforms‐binding to the major glycosaminoglycans of the extracellular matrix , 1999, FEBS letters.
[37] Y. Marcel,et al. ApoE of the HepG2 cell surface includes a major pool associated with chondroitin sulfate proteoglycans. , 1999, Biochemistry.
[38] R. Mahley,et al. Differential Cellular Accumulation/Retention of Apolipoprotein E Mediated by Cell Surface Heparan Sulfate Proteoglycans , 1998, The Journal of Biological Chemistry.
[39] J. Weiler,et al. Glycosaminoglycan‐protein interactions: definition of consensus sites in glycosaminoglycan binding proteins , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.
[40] A. Cooper. Hepatic uptake of chylomicron remnants. , 1997, Journal of lipid research.
[41] M. Salmivirta,et al. Heparan sulfate : a piece of information , 2004 .
[42] P. Gaffney,et al. Interaction of heparin with fibrinogen using surface plasmon resonance technology: investigation of heparin binding site on fibrinogen. , 1996, Thrombosis research.
[43] D. Holtzman,et al. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[44] K. Williams,et al. The response-to-retention hypothesis of early atherogenesis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[45] K. Weisgraber,et al. Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization. , 1993, The Journal of biological chemistry.
[46] D A Agard,et al. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. , 1991, Science.
[47] K. Weisgraber,et al. Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains. , 1988, The Journal of biological chemistry.
[48] R. Mahley,et al. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.
[49] R. Mahley,et al. Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3. , 1986, The Journal of biological chemistry.
[50] J. Sparrow,et al. Binding of a high reactive heparin to human apolipoprotein E: identification of two heparin-binding domains. , 1986, Biochemical and biophysical research communications.
[51] B. Sörbo,et al. Turbidimetry of inorganic sulfate, ester sulfate, and total sulfur in urine. , 1980, Clinical chemistry.
[52] A. Gotto,et al. Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. , 1973, Biochemistry.
[53] A. Rapp,et al. Role of chondroitin sulphate in the uptake of beta-VLDL by brain cells. , 2005, European Journal of Neuroscience.
[54] R. Mahley,et al. Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.
[55] R. Mahley,et al. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. , 1999, Journal of lipid research.
[56] R. Karlsson,et al. Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. , 1997, Journal of immunological methods.
[57] D. Myszka,et al. Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. , 1997, Current opinion in biotechnology.
[58] K. Weisgraber. Apolipoprotein E: structure-function relationships. , 1994, Advances in protein chemistry.